Purchase Order 75N91025P00075
Award Date
1/28/25
Potential Completion Date
1/27/26
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Roche Diagnostics Corporation for a service agreement to provide Ventana Benchmark Ultra Immunostainers. The contract has a ceiling value of $15,649.32 and a period of performance ending on March 24, 2026. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $15,649.32 contract is for a service agreement to provide Roche's Ventana Benchmark Ultra immunostainer, which is a laboratory instrument used for automated immunohistochemistry and in situ hybridization staining procedures. The contract does not have a...
This is a delivery order contract awarded by the National Cancer Institute to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra immunostainers. The $10,665.93 firm fixed price contract has an ultimate completion date of November 29, 2024. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical equipment. The contract, valued at $79,779.95, is for the supply of Ventana/Roche reagents, antibodies, and disposables to support bone marrow biopsies and testing in the NIH Clinical Center's Hematology/Histology laboratory. This non-competitive award was made under simplified acquisition...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of lab supplies, including reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra Immunostainers. The $10,470.37 firm-fixed price Delivery Order was awarded on January 31, 2018 by the National Cancer Institute, with a completion date of February 28, 2018. The contract is not set aside. Roche Diagnostics is a manufacturer and distributor of in vitro...
This is a delivery order awarded by the National Cancer Institute to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra immunostainers. The firm fixed-price contract has a ceiling value of $17,786.27 and a period of performance ending on October 30, 2017. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides reagents and consumables for cancer diagnostics and research. The $47,639.33 fixed-price delivery order was issued by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract supports the agency's Major Program Code for reagents and consumables for Ventana Medical Systems' Benchmark Ultra Immunostainers. Roche Diagnostics, a...
This is a $15,649.32 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The service agreement, which has no set-aside designation, covers the supply of laboratory instruments, reagents, test kits, and associated products and services through December 2025. Roche Diagnostics, a manufacturer of in vitro diagnostics, holds several Indefinite Delivery Vehicles and Blanket...
This is a $149,329.59 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of immunohistochemical and special stain reagents by Roche Ventana and was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 16. The contract has an ultimate completion date of September 30, 2024 and was not set aside...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Roche Diagnostics Corporation for a LightCycler maintenance agreement. The potential value of the contract is $15,000.00, with a completion date of July 18, 2020. Roche Diagnostics Corporation is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated...